Author:
Qi Yuedong,Zhang Xiaojian
Publisher
Springer Science and Business Media LLC
Subject
Cell Biology,Biochemistry,General Medicine,Biophysics
Reference31 articles.
1. Azushima, K., Uneda, K., Tamura, K., Wakui, H., Ohsawa, M., Kobayashi, R., et al. (2014). Effects of single pill-based combination therapy of amlodipine and atorvastatin on within-visit blood pressure variability and parameters of renal and vascular function in hypertensive patients with chronic kidney disease. BioMed Research International, 2014, 437087.
2. Ruilope, L., & Schaefer, A. (2013). The fixed-dose combination of olmesartan/amlodipine was superior in central aortic blood pressure reduction compared with perindopril/amlodipine: a randomized, double-blind trial in patients with hypertension. Advances in Therapy, 30(12), 1086–1099.
3. Ruzyllo, W., Tendera, M., Ford, I., & Fox, K. M. (2007). Antianginal efficacy and safety of ivabradine compared with amlodipine in patients with stable effort angina pectoris: a 3-month randomised, double-blind, multicentre, noninferiority trial. Drugs, 67(3), 393–405.
4. Bramlage, P., Zemmrich, C., Gansz, A., Sturm, C. D., Fimmers, R., Nadal, J., et al. (2014). Daytime systolic ambulatory blood pressure with a two-step switch from candesartan to olmesartan monotherapy and the fixed-dose combination of olmesartan/amlodipine in patients with uncontrolled essential hypertension (SEVICONTROL-2). The Journal of Clinical Hypertension (Greenwich), 16(1), 41–46.
5. Sierkova, V. K., Kuz’minova, N. V., & Alshantti, I. S. (2009). Comparative estimation of efficiency and safety of racemic amlodipine and its S-enantiomer in hypertensive patients. Likars’ka sprava/Ministerstvo okhorony zdorov’ia Ukrainy, 3–4, 39–44.
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献